ArticleFrontiers in cardiovascular medicine2026
Incidence, prevalence, and global burden of myocarditis among individuals aged 65 and older from 1990 to 2021 across 204 countries: a critical re-analysis of data from the global burden of disease study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocarditis is an inflammatory disease of the heart muscle that can lead to significant morbidity and mortality, particularly in the elderly population (≥65 years). This study aimed to provide a comprehensive global, regional, and national burden analysis of myocarditis from 1990 to 2021, with a prediction for 2050. We employed a variety of methodologies, including the estimation of age-standardized incidence rates, prevalence, disability-adjusted life years (DALYs), and their estimated annual percentage change (EAPC). Additionally, we analyzed age, sex, and temporal trends using line graphs and trend charts, revealing the shifts in disease burden across different demographics. Joinpoint regression analysis was performed to identify significant changes in burden over time, while the relationship between disease burden and the Socio-Demographic Index (SDI) was explored through a curve plot with a dot plot overlay. Age-period-cohort analysis was conducted to assess the influences of age effects, period effects, and cohort effects on disease burden. Decomposition analysis was employed to understand the impacts of population growth, aging, and epidemiological changes on the overall burden. Furthermore, we identified key risk factors contributing to myocarditis burden through curves and attributable risk ratios. Finally, Bayesian Age-Period-Cohort (BAPC) modeling was utilized to project the disease burden of myocarditis globally until 2050. Evidence suggests that a pivotal shift in disease burden occurred after 2010, with low temperature emerging as a primary risk factor for mortality. Our findings indicate a concerning trend in the increasing burden of myocarditis among the aging population, underscoring the urgent need for targeted public health strategies and further research to mitigate this growing health crisis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.